25 studies found for:    Open Studies | "Wegener Granulomatosis"
Show Display Options
Rank Status Study
21 Recruiting Belimumab in Remission of VASculitis
Condition: Vasculitis
Interventions: Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
22 Recruiting Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Interventions: Drug: Glucocorticoids;   Drug: Rituximab
23 Unknown  Alemtuzumab for ANCA Associated Refractory Vasculitis
Conditions: Vasculitis;   Microscopic Polyangiitis;   Granulomatosis With Polyangiitis;   Wegener's
Intervention: Drug: Alemtuzumab
24 Not yet recruiting Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
Conditions: Granulomatosis, Wegener's;   Microscopic Polyangiitis
Intervention: Other: blood specimen
25 Recruiting Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab
Condition: ANCA-associated Vasculitides
Interventions: Drug: rituximab;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-25) Next Page   
Indicates status has not been verified in more than two years